<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00775021</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0814</org_study_id>
    <secondary_id>ID08-34</secondary_id>
    <nct_id>NCT00775021</nct_id>
  </id_info>
  <brief_title>A Clinical Comparison of Two Daily Disposable Contact Lenses.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the clinical performance of two daily disposable
      contact lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Comfort</measure>
    <time_frame>1 week</time_frame>
    <description>Subjects rated study contact lens for overall comfort using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inferior Region Corneal Staining</measure>
    <time_frame>1 week</time_frame>
    <description>The investigator assessed abrasion to the lower portion of the cornea using the following scale:0 = None 1 = Slight micropunctate (1-10 spots) 2 = Moderate micropunctate (11-20 spots) 3 = Severe micropunctate (&gt;20 spots)4 = Slight macropunctate (1-5 spots) 5 = Moderate macropuntate (&gt;5-10 spots) 6 = Severe macropunctate (&gt;10 spots) 7 = Slight patch (1-2mm)8 = Moderate patch (&gt;2-4mm) 9 = Severe patch (&gt;4mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End of the Day Comfort</measure>
    <time_frame>1 week</time_frame>
    <description>Subjects rated study contact lens comfort at the end of a day of lens wear using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Initial Comfort</measure>
    <time_frame>1 Week</time_frame>
    <description>Subjects rated study contact lens for comfort immediately when they first put the lenses on using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Lens Handling</measure>
    <time_frame>1 week</time_frame>
    <description>Subjects rated study contact lens for overall ease of handling using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>etafilcon A/nelfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>etafilcon A contact lens worn first and nelfilcon A contact lens worn second</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nelfilcon A/etafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>nelfilcon A contact lens worn first and etafilcon A contact lens second.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A</intervention_name>
    <description>Contact Lens</description>
    <arm_group_label>etafilcon A/nelfilcon A</arm_group_label>
    <arm_group_label>nelfilcon A/etafilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A</intervention_name>
    <description>Contact Lens</description>
    <arm_group_label>etafilcon A/nelfilcon A</arm_group_label>
    <arm_group_label>nelfilcon A/etafilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18 years to 45 years

          -  Current daily soft contact lens as habitual optical correction:

          -  Refraction:

               -  Best sphere (corrected for back vertex distance) -1.00 to -6.00D

               -  Cylinder 0.00 to - 0.75D

          -  Best spectacle corrected visual acuity of 6/9 or better in each eye

          -  Willingness to adhere to the instructions set in the clinical protocol

          -  Signature of the subject on the informed consent form

        Exclusion Criteria:

          -  Systemic or ocular allergies which might interfere with contact lens wear

          -  Systemic disease which might interfere with contact lens wear

          -  Ocular disease which might interfere with contact lens wear (e.g. hypoesthesia,
             insufficient lacrimal secretion)

          -  Use of medication which might interfere with contact lens wear

          -  Active ocular infection

          -  Use of ocular medication

          -  Significant ocular anomaly

          -  Presence of two or more corneal scars in either eye

          -  Pregnancy or lactation

          -  Any medical condition that might be prejudicial to the study

          -  Participated in any other clinical studies in the past month

          -  Currently wears monovision
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Otometry Technology Group, Ltd.</name>
      <address>
        <city>London</city>
        <zip>SW1E 6AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2008</study_first_submitted>
  <study_first_submitted_qc>October 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2008</study_first_posted>
  <results_first_submitted>February 7, 2011</results_first_submitted>
  <results_first_submitted_qc>February 7, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 3, 2011</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Etafilcon A/Nelfilcon A</title>
          <description>etafilcon A contact lens worn first and nelfilcon A contact lens worn second</description>
        </group>
        <group group_id="P2">
          <title>Nelfilcon A/Etafilcon A</title>
          <description>nelfilcon A contact lens worn first and etafilcon A contact lens second.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Total Participants</title>
          <description>Total number of participants that completed the study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="121"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.7" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Overall Comfort</title>
        <description>Subjects rated study contact lens for overall comfort using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
        <time_frame>1 week</time_frame>
        <population>Analysis includes all participants that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>All subjects that wore etafilcon A contact lenses and completed the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>All subjects that wore nelfilcon A contact lenses and completed the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Comfort</title>
          <description>Subjects rated study contact lens for overall comfort using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
          <population>Analysis includes all participants that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6685" spread="0.1141"/>
                    <measurement group_id="O2" value="3.4352" spread="0.1148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that etafilcon A contact lenses will have equal to ro higher ratings of overall comfort than nelfilcon A contact lenses.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.2334</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1618</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.03501</ci_lower_limit>
            <ci_upper_limit>0.2334</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as etafilconA minus nelfilcon A. Analysis is adjusted for lens type, period, lens type by period interaction, gender, lens type by gender interaction as fixed effects, subject nested within site as random effect.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Inferior Region Corneal Staining</title>
        <description>The investigator assessed abrasion to the lower portion of the cornea using the following scale:0 = None 1 = Slight micropunctate (1-10 spots) 2 = Moderate micropunctate (11-20 spots) 3 = Severe micropunctate (&gt;20 spots)4 = Slight macropunctate (1-5 spots) 5 = Moderate macropuntate (&gt;5-10 spots) 6 = Severe macropunctate (&gt;10 spots) 7 = Slight patch (1-2mm)8 = Moderate patch (&gt;2-4mm) 9 = Severe patch (&gt;4mm)</description>
        <time_frame>1 week</time_frame>
        <population>Analysis includes all participants that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>All subjects that wore etafilcon A contact lenses and completed the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>All subjects that wore nelfilcon A contact lenses and completed the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Inferior Region Corneal Staining</title>
          <description>The investigator assessed abrasion to the lower portion of the cornea using the following scale:0 = None 1 = Slight micropunctate (1-10 spots) 2 = Moderate micropunctate (11-20 spots) 3 = Severe micropunctate (&gt;20 spots)4 = Slight macropunctate (1-5 spots) 5 = Moderate macropuntate (&gt;5-10 spots) 6 = Severe macropunctate (&gt;10 spots) 7 = Slight patch (1-2mm)8 = Moderate patch (&gt;2-4mm) 9 = Severe patch (&gt;4mm)</description>
          <population>Analysis includes all participants that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7004" spread="0.0643"/>
                    <measurement group_id="O2" value="0.8085" spread="0.0643"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that eyes that wore etafilcon A contact lenses will have less inferior region corneal staining than eyes that wore nelfilcon A contact lenses.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.1080</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.07768</dispersion_value>
            <ci_percent>98.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.1080</ci_lower_limit>
            <ci_upper_limit>0.06501</ci_upper_limit>
            <estimate_desc>Mean difference calculated etafilcon A minus nelfilcon A. Analysis adjusted for lens type, period, lens by period interaction, gender, lens by gender interaction as fixed effects, subject nested within site and eye within subject as random effect.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>End of the Day Comfort</title>
        <description>Subjects rated study contact lens comfort at the end of a day of lens wear using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
        <time_frame>1 week</time_frame>
        <population>Analysis includes all participants that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>All subjects that wore etafilcon A contact lenses and completed the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>All subjects that wore nelfilcon A contact lenses and completed the study.</description>
          </group>
        </group_list>
        <measure>
          <title>End of the Day Comfort</title>
          <description>Subjects rated study contact lens comfort at the end of a day of lens wear using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
          <population>Analysis includes all participants that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.148" spread="0.127"/>
                    <measurement group_id="O2" value="2.7479" spread="0.1274"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that etafilcon A contact lenses have equal to or higher comfort ratings at the end of the day than nelfilcon A.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.4001</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1799</dispersion_value>
            <ci_percent>98.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.0055</ci_lower_limit>
            <ci_upper_limit>0.4001</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as etafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Initial Comfort</title>
        <description>Subjects rated study contact lens for comfort immediately when they first put the lenses on using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
        <time_frame>1 Week</time_frame>
        <population>Analysis includes all participants that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>All subjects that wore etafilcon A contact lenses and completed the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>All subjects that wore nelfilcon A contact lenses and completed the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Initial Comfort</title>
          <description>Subjects rated study contact lens for comfort immediately when they first put the lenses on using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
          <population>Analysis includes all participants that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5694" spread="0.1229"/>
                    <measurement group_id="O2" value="3.6783" spread="0.1233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that etafilcon A contact lenses will have equal or higher ratings of initial comfort than nelfilcon A contact lenses.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.1088</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1741</dispersion_value>
            <ci_percent>98.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.5016</ci_lower_limit>
            <ci_upper_limit>-0.1088</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as etafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Lens Handling</title>
        <description>Subjects rated study contact lens for overall ease of handling using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
        <time_frame>1 week</time_frame>
        <population>Analysis includes all participants that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>All subjects that wore etafilcon A contact lenses and completed the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>All subjects that wore nelfilcon A contact lenses and completed the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Lens Handling</title>
          <description>Subjects rated study contact lens for overall ease of handling using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
          <population>Analysis includes all participants that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.546" spread="0.1189"/>
                    <measurement group_id="O2" value="3.2971" spread="0.1187"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that etaflicon A contact lenses have equal to or higher ratings of ease of handling than nelfilcon A contact lenses.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.2489</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.168</dispersion_value>
            <ci_percent>98.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.1301</ci_lower_limit>
            <ci_upper_limit>0.2489</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as etafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Etafilcon A</title>
          <description>etafilcon A contact lenses</description>
        </group>
        <group group_id="E2">
          <title>Nelfilcon A</title>
          <description>nelfilcon A contact lenses.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="122"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="122"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="122"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="122"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kurt Moody, Director Design R&amp;D</name_or_title>
      <organization>Vistakon</organization>
      <phone>904-443-3088</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

